PHS
PRAX icon

PFM Health Sciences’s Praxis Precision Medicines PRAX Stock Holding History

PFM Health Sciences’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
38,575
+3,137
+9% +$993K 1.11% 32
2026
Q1 		$11.4M Buy
35,438
+4,275
+14% +$1.32M 1.04% 33
2025
Q4 		$9.18M Sell
31,163
-29,415
-49% -$5.48M 0.92% 33
2025
Q3 		$3.21M Sell
60,578
-24,135
-28% -$1.17M 0.25% 60
2025
Q2 		$3.56M Sell
84,713
-76,153
-47% -$2.9M 0.3% 45
2025
Q1 		$6.09M Buy
160,866
+41,357
+35% +$2.58M 0.44% 41
2024
Q4 		$9.2M Sell
119,509
-63,583
-35% -$4.6M 0.57% 44
2024
Q3 		$10.5M Sell
183,092
-270,054
-60% -$14.6M 0.6% 39
2024
Q2 		$18.7M Sell
453,146
-24,459
-5% -$1.16M 0.93% 35
2024
Q1 		$29.1M Sell
477,605
-178,943
-27% -$8.03M 1.37% 26
2023
Q4 		$14.6M Buy
656,548
+61,882
+10% +$1.11M 0.88% 37
2023
Q3 		$15.3M Buy
594,666
+1,882
+0.3% +$35.6K 0.72% 45
2023
Q2 		$10.2M Buy
592,784
+447,678
+309% +$6.85M 0.4% 60
2023
Q1 		$1.76M Sell
145,106
-40,058
-22% -$1.69M 0.08% 73
2022
Q4 		$6.61M Sell
185,164
-45,404
-20% -$1.42M 0.24% 72
2022
Q3 		$7.85M Buy
230,568
+10,745
+5% +$535K 0.28% 69
2022
Q2 		$8.08M Buy
219,823
+162,168
+281% +$17.3M 0.31% 64
2022
Q1 		$8.83M Buy
57,655
+15,261
+36% +$3.13M 0.33% 56
2021
Q4 		$12.5M Buy
42,394
+12,036
+40% +$3.53M 0.43% 53
2021
Q3 		$8.42M Hold
30,358
– – 0.25% 66
2021
Q2 		$8.32M Buy
+30,358
New +$10.9M 0.26% 67

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PFM Health Sciences's PRAX Position: Q2 2026 in Review

PFM Health Sciences increased its Praxis Precision Medicines (PRAX) stake by 8.9% in Q2 2026, buying an estimated $993K and bringing the position to 38,575 shares worth $12.9M. The position accounts for 1.11% of the portfolio, ranked #32.

PFM Health Sciences first reported a position in PRAX in Q2 2021 and has held it in 21 quarters since. The position peaked at $29.1M in Q1 2024. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • PFM Health Sciences held 38,575 shares of Praxis Precision Medicines worth $12.9M as of Q2 2026.
  • PFM Health Sciences bought 3,137 Praxis Precision Medicines shares in Q2 2026, an estimated $993K.
  • Praxis Precision Medicines made up 1.11% of PFM Health Sciences's portfolio in Q2 2026, its #32 holding.
  • PFM Health Sciences first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 21 quarters since.
  • PFM Health Sciences's Praxis Precision Medicines position peaked at $29.1M in Q1 2024.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.